Background A previously healthy 32-year-old man presented with pain in his chest, ankle, and hip. His musculoskeletal pain progressed over the course of 6 months to the point of difficulty with ...
Background A 17-year-old Filipino male hemodialysis patient presented for renal transplant evaluation. He had significant skeletal abnormalities characterized by bone pain, an inability to walk, and ...
Panel A shows the marked decreases in FGF23 levels (black curve) induced by infigratinib (gray bars indicate doses of the drug), which reversed when the patient was not receiving the drug. The timing ...
The FDA as approved Crysvita® (burosumab-twza; Ultragenyx) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia associated with phosphaturic ...
A research team at Uppsala University has identified a clear link between osteomalacia – a form of bone softening commonly caused by vitamin D deficiency – and a fivefold increased risk of emergency ...
Hosted on MSN
Study finds clear link between osteomalacia and increased risk of complicated deliveries
A research team at Uppsala University has identified a clear link between osteomalacia – a form of bone softening commonly caused by vitamin D deficiency – and a fivefold increased risk of emergency ...
Osteomalacia, or soft bone disease, is caused by vitamin D deficiency and can silently affect pregnant women Women with osteomalacia were five times more likely to need assisted deliveries Immigrant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback